Michigan State University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Michigan State University sits in the top decile of US sponsors by registered trial count (#217 of 15,742 sponsors by registered trial count).
Michigan State University: 120 sponsored US clinical trials, 24 recruiting.
Michigan State University sponsors 120 registered US clinical trials on ClinicalTrials.gov, 24 of them currently recruiting, and 79 completed. 4 of these trials are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Vaccine-Preventable Diseases, with 2 trials.
Top-decile sponsor footprint
Michigan State University ranks in the top decile of sponsors by registered trial count (#217 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
79 of 86 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
120 total, page 1 of 3
SMART Diets for MASLD
NCT07459504
Empowering Vietnamese Americans
NCT07164391
Impact of Room Light on Uterine Contractions and Labor Progression in Pregnancy
NCT04521972
Playing Game to Learn About Children's Vaccine Project
NCT05984849
Support for Bereaved Cancer Caregivers
NCT06662409
Family Health Histories: Creating a Culturally Tailored Tool to Reduce Health Disparities in the Black Community
NCT05358964
Multilevel Community-Centered Intervention to Reduce Pregnancy Related and Associated Morbidity and Mortality (PRAMM) Disparities
NCT07025057
How Simplified Language Affects Comprehension and Learning in Young Children With Down Syndrome
NCT06951516
Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI
NCT07301905
Scaling up Maternal Health Equity Best Practices
NCT06541951
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
NCT06232304
Engaging College Students in Developing and Testing a Video-based Intervention for HPV Vaccination Promotion
NCT06397378
Food-Body-Mind Intervention (16 Weeks)
NCT06597474
Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy
NCT06529029
AM vs PM Exercise Training
NCT06042439
Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements
NCT07599696
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
NCT05564663
How Simplified Language Affects Comprehension and Learning in Young Autistic Children
NCT05707923
The Development of Stuttering in Young Children
NCT06578416
The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention
NCT05700760
Reducing Lead Dust Exposure in Older Housing
NCT07485608
Treating Chronic Cervicogenic Head and Neck Pain
NCT05617365
IPT for Major Depression Following Perinatal Loss: Healing After Loss (HeAL)
NCT04629599
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
NCT01904188
MOSAIC (MOthers' AdvocateS In the Community) for Pregnant Women and Mothers of Children Under 5 With Experience of Intimate Partner Violence
NCT05106361
Game-Based Intervention to Promote HPV Vaccination
NCT06162676
HELP Pain Training Program
NCT05698290
Efficacy of the Apollo System for Children With ADHD
NCT05308706
Decreasing Cardiovascular Risk for Patients With Diabetes
NCT04874116
Evaluation of SLEEP Program
NCT04727619
Guys/Girls Opt for Activities for Life Trial (GOAL) to Increase Young Adolescents' Physical Activity and Healthy Eating
NCT04213014
Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors
NCT01535911
PURSUIT: A Technologically Augmented School-based Program to Improve Child Coping and Prevent Substance Use.
NCT07266740
The Impact of Light Exposure on Cognitive Function in Classrooms
NCT06325150
Nature IDEAS Study: An RCT to Increase Time Spent in Nature Among University Students
NCT06633367
The Effects of Exercise on Emotion Regulation and Cognitive Control in PTSD
NCT05643716
MOSAIC (MOthers' AdvocateS In the Community) for Pregnant Women and Mothers of Children Under 5 With Experience of Intimate Partner Violence (MOSAIC Plus) Open Trial
NCT05968534
Food-Body-Mind Intervention
NCT05964218
Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy
NCT04332172
Rural Tailored COVID-19 Communication to Promote SARS-CoV-2 Antibody Testing in Saliva
NCT06085547
OMT & Intractable Singultus
NCT07149025
Cluster-randomized Controlled Trial of Mindfulness-Based Cognitive Therapy Effects on Anxiety and Stress
NCT06019299
Montmorency Cherry Supplementation, Sleep, and Inflammation
NCT05700643
Exercise and Vascular Function in Postmenopausal Females With Hypertension
NCT05597033
Eat My ABCs Project
NCT05780008
Peer Navigation for Individuals With Serious Mental Illness Leaving Jail
NCT04256954
Examining the Active Ingredients of Consultation of a Parent-mediated Intervention for Autism
NCT04654117
The Role of Osteopathic Manipulative Medicine in Recovery From Concussions
NCT04932278
FirstStep2Health Intervention
NCT04164277
Happy Family, Healthy Kids Program
NCT04183179
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 7 |
| Phase 4 | 4 |
Therapeutic Areas
What is open in the Michigan State University pipeline
24 recruiting of 120 indexed (20% open); 79 completed (66%).
Phase mix: 4 late (III/IV) vs 14 early (I/II) (early-phase heavy).
Top condition: Vaccine-Preventable Diseases (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Michigan State University: open-pipeline peers nationwide
Peers matched on 120 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Michigan State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 120 trials (± recruiting share)
- Children's Hospital Los Angeles · 119 trials · 29% recruiting
- Jaeb Center for Health Research · 119 trials · 14% recruiting
- Medtronic - MITG · 119 trials · 4% recruiting
- West Virginia University · 122 trials · 18% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
Related
What to do with this Michigan State University page
120 registered trials is a research-attention snapshot, not an endorsement of Michigan State University or any single study.
- 24 of Michigan State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Vaccine-Preventable Diseases is the condition Michigan State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Vaccine-Preventable Diseases trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Michigan State University pipeline card: 120 registered trials from official public datasets.Report a data error.